查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2111091

2034年醫藥玻璃包裝市場預測－全球產品類型、玻璃類型、包裝形式、藥品類型、容量、最終用戶和地區分析

Pharmaceutical Glass Packaging Market Forecasts to 2034 - Global Analysis By Product Type, Glass Type, Packaging Format, Drug Type, Capacity, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球醫藥玻璃包裝市場規模將達到 228 億美元，到 2034 年將達到 379 億美元，預測期內複合年成長率為 6.6%。

醫藥玻璃包裝是指一系列用於保護、儲存和供應注射劑、疫苗、生物製劑和液體等藥品的玻璃容器和包裝解決方案。這些解決方案包括管瓶、安瓿瓶、藥筒、注射器、藥瓶和管狀玻璃容器，採用各種類型的玻璃製造，適用於初級和二級包裝應用，包括I型硼矽酸玻璃、II型處理鈉鈣玻璃、III型鈉鈣玻璃、琥珀色玻璃和透明燧石玻璃。這項技術使製藥公司能夠在滿足容器和密封系統監管要求的同時，確保藥物的穩定性、安全性和有效性。

生物製藥和注射的需求不斷成長

生物製藥、生物相似藥和注射劑的需求不斷成長，是推動醫藥玻璃包裝市場發展的主要動力。生物製藥和注射需要具有卓越化學耐久性、熱穩定性和阻隔性的專用玻璃包裝，以保護敏感藥物。慢性病盛行率的上升和生物製藥研發管線的擴展，進一步推動了對高品質玻璃包裝的需求。隨著生物製藥在藥物研發中佔據越來越大的佔有率，對可靠玻璃包裝的需求也顯著成長。

高昂的製造成本和複雜的供應鏈

高昂的製造成本和複雜的供應鏈限制著醫藥玻璃包裝市場的阻礙因素。生產高品質的醫藥玻璃需要對專用生產設施、品管系統和法規遵從性進行大量投資。供應鏈中斷，例如影響石英砂和能源供應等原料的供應，會對生產成本和供應狀況產生負面影響。此外，滿足容器和密封系統嚴格的法規要求也推高了營運成本。這些成本和供應方面的限制因素可能會限制市場成長。

先進玻璃塗層和分層防止技術的開發

先進玻璃塗層和防分層技術的開發為醫藥玻璃包裝市場帶來了巨大的機會。創新塗層能夠改善藥物相容性，減少蛋白質吸附，並防止可能影響藥物品質的玻璃分層。表面處理技術可增強玻璃容器的化學耐久性，從而更好地保護敏感的生物製藥產品。隨著藥物配方日益複雜和精細，對先進玻璃包裝解決方案的需求持續成長，這為提供創新塗層技術的製造商創造了更多機會。

與聚合物和塑膠包裝材料的競爭

來自聚合物和塑膠等替代包裝材料的競爭對醫藥玻璃包裝市場構成重大威脅。塑膠容器具有破損率低、重量輕、在某些應用中還能節省成本等優點。聚合物材料的進步也提高了其與藥品的相容性。在對化學相容性和阻隔性要求較不嚴格的應用領域，替代材料的激增可能會對玻璃包裝的使用造成壓力。這種競爭環境可能會限制某些細分市場的成長。

新型冠狀病毒（COVID-19）的影響：

新冠疫情透過疫苗包裝需求激增和供應鏈中斷，對醫藥玻璃包裝市場造成了重大影響。疫苗管瓶和注射器的迫切需求催生了對醫藥玻璃包裝前所未有的需求。製造商擴大產能以滿足全球疫苗包裝需求。然而，包括原料供應和物流在內的供應鏈挑戰影響了生產。這次疫情凸顯了可靠的醫藥包裝供應鏈的重要性，以及玻璃包裝在全球健康領域的關鍵角色。

在預測期內，管瓶產品預計將佔據最大的市場佔有率。

預計在預測期內，管瓶包裝仍將佔據最大的市場佔有率，這主要得益於管瓶在注射劑、疫苗和生物製藥領域的廣泛應用，這些領域對無菌性有著極高的要求。管瓶具有優異的化學穩定性、耐熱性和阻隔性能，這對敏感型藥物至關重要。注射劑和疫苗需求的不斷成長也鞏固了該細分市場的主導地位。隨著製藥業不斷拓展生物製藥和疫苗的研發，管瓶仍是注射劑產品的主要包裝選擇。

預計在預測期內，I型玻璃細分市場將呈現最高的複合年成長率。

在預測期內，由於硼矽酸玻璃具有優異的化學耐久性和熱穩定性，尤其適用於敏感生物製藥和注射劑，因此I型玻璃市場預計將呈現最高的成長率。 I型玻璃具有出色的抗化學腐蝕和抗分層性能，使其成為pH敏感型和高價值藥物的關鍵材料。生物製藥和複雜製劑研發管線的不斷擴展正在推動市場需求。隨著藥物研發日益關注高敏感性生物製藥，I型玻璃的市佔率將持續擴大。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這主要得益於該地區對藥品研發的大量投入、大型製藥企業的聚集以及對藥品包裝的嚴格監管要求。該地區對藥品安全和品質的高度重視推動了對高品質玻璃包裝的需求。大量的藥品支出以及對生物製藥開發的重視，鞏固了其市場主導地位。此外，健全的法規結構保障了容器和密封系統的完整性，進一步加速了北美地區對玻璃包裝的採用。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於製藥行業的快速成長、生物製藥生產的擴張以及主要經濟體醫療保健支出的增加。中國、印度和韓國等國家對藥品生產和包裝的需求正在顯著成長。政府促進國內藥品生產的舉措以及合約研發生產機構（CDMO）的興起也推動了該地區市場的擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球醫藥玻璃包裝市場：依產品類型分類

  • 管瓶
  • 安瓿
  • 墨水匣
  • 注射器
  • 瓶子
  • 管狀玻璃容器
  • 其他玻璃容器

第6章 全球醫藥玻璃包裝市場：依玻璃類型分類

  • I型（硼矽酸玻璃）
  • 第二類（處理過的鈉鈣玻璃）
  • 第三類（鈉鈣玻璃）
  • 琥珀色玻璃
  • 透明（燧石）玻璃

第7章 全球醫藥玻璃包裝市場：依包裝類型分類

  • 初級包裝
  • 二級包裝

第8章 全球醫藥玻璃包裝市場：依藥品類型分類

  • 注射藥物
  • 疫苗
  • 生物製劑和生物相似藥
  • 小分子藥物
  • 口服液體藥物
  • 眼科藥物

第9章 全球醫藥玻璃包裝市場：依產能分類

  • 少於10毫升
  • 10～50 mL
  • 51～100 mL
  • 100毫升或更多

第10章 全球醫藥玻璃包裝市場：依最終用戶分類

  • 製藥公司
  • 生技公司
  • 合約研發生產組織（CDMO）
  • 合約包裝營運商 (CPO)
  • 研究和學術機構

第11章 全球醫藥玻璃包裝市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • SCHOTT Pharma AG & Co. KGaA
  • Gerresheimer AG
  • Stevanato Group SpA
  • SGD Pharma
  • Corning Incorporated
  • Nipro Corporation
  • Bormioli Pharma SpA
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Stolzle Glass Group
  • West Pharmaceutical Services, Inc.
  • Ardagh Group SA
  • DWK Life Sciences GmbH
  • Beatson Clark Ltd.
  • Sisecam Group
  • Owens-Illinois, Inc.
Product Code: SMRC38791

According to Stratistics MRC, the Global Pharmaceutical Glass Packaging Market is accounted for $22.8 billion in 2026 and is expected to reach $37.9 billion by 2034, growing at a CAGR of 6.6% during the forecast period. Pharmaceutical Glass Packaging refers to the comprehensive range of glass containers and packaging solutions designed to protect, preserve, and deliver pharmaceutical products including injectable drugs, vaccines, biologics, and liquid medicines. These solutions encompass vials, ampoules, cartridges, syringes, bottles, and tubular glass containers manufactured from various glass types including Type I borosilicate glass, Type II treated soda-lime glass, Type III soda-lime glass, amber glass, and clear flint glass for primary and secondary packaging applications. This technology helps pharmaceutical companies ensure drug stability, safety, and efficacy while meeting regulatory requirements for container closure systems.

Market Dynamics:

Driver:

Growing demand for biologics and injectable drugs

The increasing demand for biologics, biosimilars, and injectable drugs serves as a primary driver for the Pharmaceutical Glass Packaging market. Biologics and injectable formulations require specialized glass packaging that provides superior chemical durability, thermal stability, and barrier properties to protect sensitive drug products. The rising prevalence of chronic diseases and the growing pipeline of biologic drugs drive demand for high-quality glass packaging. As biologics represent a growing share of pharmaceutical development, the need for reliable glass packaging continues to expand significantly.

Restraint:

High manufacturing costs and supply chain complexities

The significant manufacturing costs and supply chain complexities pose restraints to the Pharmaceutical Glass Packaging market. Producing high-quality pharmaceutical glass requires substantial investment in specialized manufacturing equipment, quality control systems, and regulatory compliance. Supply chain disruptions affecting raw materials including silica sand and energy inputs impact production costs and availability. The complexity of meeting stringent regulatory requirements for container closure systems adds to operational costs. These cost and supply constraints can limit market growth.

Opportunity:

Development of advanced glass coatings and delamination prevention

The development of advanced glass coatings and delamination prevention technologies presents significant opportunities for the Pharmaceutical Glass Packaging market. Innovative coatings improve drug compatibility, reduce protein adsorption, and prevent glass delamination that can compromise drug quality. Surface treatment technologies enhance the chemical durability of glass containers for sensitive biologics. As drug formulations become more complex and sensitive, the demand for advanced glass packaging solutions continues to grow, creating opportunities for manufacturers offering innovative coating technologies.

Threat:

Competition from polymer and plastic packaging alternatives

Competition from polymer and plastic packaging alternatives poses significant threats to the Pharmaceutical Glass Packaging market. Plastic containers offer advantages including reduced breakage, lighter weight, and lower cost for certain applications. Advances in polymer materials have improved compatibility with drug products. The availability of alternatives can pressure glass packaging adoption in applications where chemical compatibility and barrier requirements are less demanding. This competitive dynamic can limit growth in certain segments.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Pharmaceutical Glass Packaging market through increased demand for vaccine packaging and supply chain disruptions. The urgent need for vaccine vials and syringes created unprecedented demand for pharmaceutical glass packaging. Manufacturers expanded production capacity to meet global vaccine packaging requirements. Supply chain challenges including raw material availability and logistics affected production. The pandemic highlighted the critical importance of reliable pharmaceutical packaging supply chains and the essential role of glass packaging in global health.

The vials segment is expected to be the largest during the forecast period

The vials segment is expected to account for the largest market share during the forecast period, driven by the widespread use of glass vials for parenteral drugs, vaccines, and biologics requiring sterile containment. Vials provide superior chemical stability, thermal resistance, and barrier properties essential for sensitive drug products. The growing demand for injectable drugs and vaccines supports continued dominance. As the pharmaceutical industry expands biologic and vaccine development, vials remain the primary packaging choice for parenteral products.

The Type I glass segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Type I glass segment is predicted to witness the highest growth rate, due to the superior chemical durability and thermal stability of borosilicate glass for sensitive biologics and injectable drugs. Type I glass provides excellent resistance to chemical attack and delamination, making it essential for pH-sensitive and high-value drug products. The growing pipeline of biologic drugs and complex formulations drives demand. As pharmaceutical development increasingly focuses on sensitive biologics, Type I glass continues to gain market share.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by substantial investment in pharmaceutical R&D, the presence of major pharmaceutical companies, and strong regulatory requirements for drug packaging. The region's focus on drug safety and quality creates demand for high-quality glass packaging. Significant pharmaceutical spending and the emphasis on biologics development contribute to market leadership. Additionally, robust regulatory frameworks supporting container closure system integrity further fuel adoption in North America.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapid growth of the pharmaceutical industry, expanding biologics manufacturing, and increasing healthcare spending across major economies. Countries such as China, India, and South Korea are witnessing significant growth in pharmaceutical production and packaging demand. Government initiatives promoting domestic pharmaceutical manufacturing and the rise of contract development and manufacturing organizations further contribute to regional market expansion.

Key players in the market

Some of the key players in the Pharmaceutical Glass Packaging Market include SCHOTT Pharma AG & Co. KGaA, Gerresheimer AG, Stevanato Group S.p.A., SGD Pharma, Corning Incorporated, Nipro Corporation, Bormioli Pharma S.p.A., Shandong Pharmaceutical Glass Co. Ltd., Stolzle Glass Group, West Pharmaceutical Services Inc., Ardagh Group S.A., DWK Life Sciences GmbH, Beatson Clark Ltd., Sisecam Group, and Owens-Illinois Inc.

Key Developments:

In June 2026, SCHOTT Pharma announced a major expansion of its pharmaceutical glass packaging production capacity to meet growing demand for vaccine vials and biologics packaging. The expansion includes new glass conversion capabilities and enhanced quality control systems.

In May 2026, Gerresheimer introduced a new line of high-performance glass syringes featuring advanced surface treatment for reduced protein adsorption and improved drug compatibility.

Product Types Covered:

  • Vials
  • Ampoules
  • Cartridges
  • Syringes
  • Bottles
  • Tubular Glass Containers
  • Other Glass Containers

Glass Types Covered:

  • Type I (Borosilicate Glass)
  • Type II (Treated Soda-Lime Glass)
  • Type III (Soda-Lime Glass)
  • Amber Glass
  • Clear (Flint) Glass

Packaging Formats Covered:

  • Primary Packaging
  • Secondary Packaging

Drug Types Covered:

  • Injectable Drugs
  • Vaccines
  • Biologics & Biosimilars
  • Small Molecule Drugs
  • Oral Liquid Medicines
  • Ophthalmic Drugs

Capacities Covered:

  • Less than 10 mL
  • 10-50 mL
  • 51-100 mL
  • Above 100 mL

End Users Covered:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Contract Packaging Organizations (CPOs)
  • Research & Academic Institutes

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pharmaceutical Glass Packaging Market, By Product Type

  • 5.1 Vials
  • 5.2 Ampoules
  • 5.3 Cartridges
  • 5.4 Syringes
  • 5.5 Bottles
  • 5.6 Tubular Glass Containers
  • 5.7 Other Glass Containers

6 Global Pharmaceutical Glass Packaging Market, By Glass Type

  • 6.1 Type I (Borosilicate Glass)
  • 6.2 Type II (Treated Soda-Lime Glass)
  • 6.3 Type III (Soda-Lime Glass)
  • 6.4 Amber Glass
  • 6.5 Clear (Flint) Glass

7 Global Pharmaceutical Glass Packaging Market, By Packaging Format

  • 7.1 Primary Packaging
  • 7.2 Secondary Packaging

8 Global Pharmaceutical Glass Packaging Market, By Drug Type

  • 8.1 Injectable Drugs
  • 8.2 Vaccines
  • 8.3 Biologics & Biosimilars
  • 8.4 Small Molecule Drugs
  • 8.5 Oral Liquid Medicines
  • 8.6 Ophthalmic Drugs

9 Global Pharmaceutical Glass Packaging Market, By Capacity

  • 9.1 Less than 10 mL
  • 9.2 10-50 mL
  • 9.3 51-100 mL
  • 9.4 Above 100 mL

10 Global Pharmaceutical Glass Packaging Market, By End User

  • 10.1 Pharmaceutical Companies
  • 10.2 Biotechnology Companies
  • 10.3 Contract Development & Manufacturing Organizations (CDMOs)
  • 10.4 Contract Packaging Organizations (CPOs)
  • 10.5 Research & Academic Institutes

11 Global Pharmaceutical Glass Packaging Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 SCHOTT Pharma AG & Co. KGaA
  • 14.2 Gerresheimer AG
  • 14.3 Stevanato Group S.p.A.
  • 14.4 SGD Pharma
  • 14.5 Corning Incorporated
  • 14.6 Nipro Corporation
  • 14.7 Bormioli Pharma S.p.A.
  • 14.8 Shandong Pharmaceutical Glass Co., Ltd.
  • 14.9 Stolzle Glass Group
  • 14.10 West Pharmaceutical Services, Inc.
  • 14.11 Ardagh Group S.A.
  • 14.12 DWK Life Sciences GmbH
  • 14.13 Beatson Clark Ltd.
  • 14.14 Sisecam Group
  • 14.15 Owens-Illinois, Inc.

List of Tables

  • Table 1 Global Pharmaceutical Glass Packaging Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pharmaceutical Glass Packaging Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Pharmaceutical Glass Packaging Market Outlook, By Vials (2023-2034) ($MN)
  • Table 4 Global Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2023-2034) ($MN)
  • Table 5 Global Pharmaceutical Glass Packaging Market Outlook, By Cartridges (2023-2034) ($MN)
  • Table 6 Global Pharmaceutical Glass Packaging Market Outlook, By Syringes (2023-2034) ($MN)
  • Table 7 Global Pharmaceutical Glass Packaging Market Outlook, By Bottles (2023-2034) ($MN)
  • Table 8 Global Pharmaceutical Glass Packaging Market Outlook, By Tubular Glass Containers (2023-2034) ($MN)
  • Table 9 Global Pharmaceutical Glass Packaging Market Outlook, By Other Glass Containers (2023-2034) ($MN)
  • Table 10 Global Pharmaceutical Glass Packaging Market Outlook, By Glass Type (2023-2034) ($MN)
  • Table 11 Global Pharmaceutical Glass Packaging Market Outlook, By Type I (Borosilicate Glass) (2023-2034) ($MN)
  • Table 12 Global Pharmaceutical Glass Packaging Market Outlook, By Type II (Treated Soda-Lime Glass) (2023-2034) ($MN)
  • Table 13 Global Pharmaceutical Glass Packaging Market Outlook, By Type III (Soda-Lime Glass) (2023-2034) ($MN)
  • Table 14 Global Pharmaceutical Glass Packaging Market Outlook, By Amber Glass (2023-2034) ($MN)
  • Table 15 Global Pharmaceutical Glass Packaging Market Outlook, By Clear (Flint) Glass (2023-2034) ($MN)
  • Table 16 Global Pharmaceutical Glass Packaging Market Outlook, By Packaging Format (2023-2034) ($MN)
  • Table 17 Global Pharmaceutical Glass Packaging Market Outlook, By Primary Packaging (2023-2034) ($MN)
  • Table 18 Global Pharmaceutical Glass Packaging Market Outlook, By Secondary Packaging (2023-2034) ($MN)
  • Table 19 Global Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2023-2034) ($MN)
  • Table 20 Global Pharmaceutical Glass Packaging Market Outlook, By Injectable Drugs (2023-2034) ($MN)
  • Table 21 Global Pharmaceutical Glass Packaging Market Outlook, By Vaccines (2023-2034) ($MN)
  • Table 22 Global Pharmaceutical Glass Packaging Market Outlook, By Biologics & Biosimilars (2023-2034) ($MN)
  • Table 23 Global Pharmaceutical Glass Packaging Market Outlook, By Small Molecule Drugs (2023-2034) ($MN)
  • Table 24 Global Pharmaceutical Glass Packaging Market Outlook, By Oral Liquid Medicines (2023-2034) ($MN)
  • Table 25 Global Pharmaceutical Glass Packaging Market Outlook, By Ophthalmic Drugs (2023-2034) ($MN)
  • Table 26 Global Pharmaceutical Glass Packaging Market Outlook, By Capacity (2023-2034) ($MN)
  • Table 27 Global Pharmaceutical Glass Packaging Market Outlook, By Less than 10 mL (2023-2034) ($MN)
  • Table 28 Global Pharmaceutical Glass Packaging Market Outlook, By 10-50 mL (2023-2034) ($MN)
  • Table 29 Global Pharmaceutical Glass Packaging Market Outlook, By 51-100 mL (2023-2034) ($MN)
  • Table 30 Global Pharmaceutical Glass Packaging Market Outlook, By Above 100 mL (2023-2034) ($MN)
  • Table 31 Global Pharmaceutical Glass Packaging Market Outlook, By End User (2023-2034) ($MN)
  • Table 32 Global Pharmaceutical Glass Packaging Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
  • Table 33 Global Pharmaceutical Glass Packaging Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 34 Global Pharmaceutical Glass Packaging Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs) (2023-2034) ($MN)
  • Table 35 Global Pharmaceutical Glass Packaging Market Outlook, By Contract Packaging Organizations (CPOs) (2023-2034) ($MN)
  • Table 36 Global Pharmaceutical Glass Packaging Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.